Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
SUXAMETHONIUM CHLORIDE
GlaxoSmithKline (Ireland) Limited
M03AB01
SUXAMETHONIUM CHLORIDE
50 Mg/Ml
Solution for Inj/Inf
Product subject to prescription which may not be renewed (A)
Choline derivatives
Transfer Pending
1979-04-01
Reason for update: IE MAH Address change Agency Approval Date: 14 July 2015 Text Date: 06/07/2015 Text Issue and Draft No.:issue 3 draft 1 SPC Issue and Draft No.: issue 3 draft 1 CO Number: 1 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER ANECTINE® 50 MG/ML SOLUTION FOR INJECTION OR INFUSION (SUXAMETHONIUM CHLORIDE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Anectine is and what it is used for 2. What you need to know before you have Anectine 3. How to have Anectine 4. Possible side effects 5. How to store Anectine 6. Contents of the pack and other information 1. WHAT ANECTINE IS AND WHAT IT IS USED FOR Anectine contains a medicine called suxamethonium chloride. This belongs to a group of medicines called muscle relaxants. Anectine is used: to relax muscles during operations on adults and children to help insert a tube into the windpipe (endotracheal intubation), if a person needs help to breathe to reduce how stongly your muscles contract Ask your doctor if you would like more explanation about this medicine. 2. WHAT YOU NEED TO KNOW BEFORE YOU HAVE ANECTINE DO NOT USE ANECTINE IF: you are allergic to suxamethonium chloride or any of the other ingredients of Anectine injection (listed in section 6). you or a family member have reacted badly Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Anectine 50mg/ml solution for injection or infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2 ml ampoule contains 100 mg Suxamethonium Chloride Injection. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection or infusion A clear, colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Anectine Injection is an ultra-short acting, depolarising, neuromuscular blocking agent. It is used in anaesthesia as a skeletal muscle relaxant to facilitate tracheal intubation and mechanical ventilation in surgical procedures. Anectine Injection is also used to reduce the intensity of muscular contractions associated with pharmacologically or electrically-induced convulsions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _INSTRUCTIONS FOR USE_ The dose of Anectine Injection is dependent on age, body weight, the degree of muscle relaxation required and the route of administration. The usual method of Anectine Injection administration is by bolus intravenous injection. _USE BY INTRAVENOUS BOLUS INJECTION_ _Dosage in adults: _A single intravenous dose of suxamethonium chloride dihydrate of approximately 1mg/kg bodyweight will usually provide profound neuromuscular blockade and good conditions for tracheal intubation within 30-60 seconds of its administration. The duration of clinically useful neuromuscular relaxation produced by this dose is on average 2-6 minutes, although wide inter-patient variability exists. Larger single doses of Anectine Injection may slightly accelerate the speed at which neuromuscular paralysis develops, and will produce longer durations of clinically useful muscle relaxation but not in a direct dose-dependent manner; doubling the dose of Anectine Injection does not Read the complete document